We are live on ! Find out more
SGTX

Sigilon Therapeutics, Inc. Common Stock
SGTX

Delisted

SGTX was delisted on the 10th of August, 2023.

Back to rankings

Fund managers haven’t disclosed any holdings of SGTX yet.

SGTX Hedge Fund Activity: Q4 2023 in Review

0 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Sigilon Therapeutics, Inc. Common Stock (SGTX) for Q4 2023, worth a combined $0 — down 100% from $4.49K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of SGTX and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was IFP Advisors, exiting entirely with an estimated $4.49K sold.

  • 0 institutional investors held Sigilon Therapeutics, Inc. Common Stock (SGTX) as of Q4 2023, down from 1 in Q3 2023.
  • Funds reported $0 of Sigilon Therapeutics, Inc. Common Stock stock for Q4 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Sigilon Therapeutics, Inc. Common Stock positions in Q4 2023 and 1 closed out, a net change of -1 holder.
  • The largest Sigilon Therapeutics, Inc. Common Stock seller in Q4 2023 was IFP Advisors, an estimated $4.49K sold.

Based on aggregated 13F filings for Q4 2023.